AGP Picks
View all

Telecoms Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.

Press releases published on November 4, 2026

Report: 86% of Insurance Executives in Canada Believe AI Will Strengthen Customer Trust, Only 33% of Policyholders Agree
Daré Bioscience to Present at Stifel’s 2026 Healthcare Conference
Feedonomics Now Available in Amazon’s Shop Direct Merchant Workspace, Making it Easier for Brands to Get Their Products in Front of Amazon Customers
Doba Adds $20 Cash Bonus to Referral Program for Ecommerce Marketers
Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the 68th ASH Annual Meeting and Exposition
Komodor Survey Finds More Than 50% of Engineering Organizations Face Control and Governance Issues as They Scale Agentic Operations
Solu Therapeutics to Present Initial Phase 1 Results of STX-0712 and New Preclinical Data on STX-0640 in Two Oral Presentations at the 2026 ASH Annual Meeting
Kura Oncology and Kyowa Kirin to Present First Ziftomenib-FLT3 Inhibitor Clinical Data at ASH 2026
Lyell Immunopharma Announces $80 Million Private Placement to Advance Ronde-Cel Toward Planned BLA Submission
TestGrid Launches TestGrid ONE, the AI Operating System That Runs Quality Engineering
Northrop Grumman to Participate in the Baird 2026 Global Industrial Conference
Lakefront Biotherapeutics Announces Poster Presentation at the 2026 American Society of Hematology Meeting
Lakefront Biotherapeutics kondigt posterpresentatie aan op het congres van de American Society of Hematology 2026
Phase 1 Data for CITY-FXI, an RNAi Therapeutic Candidate for Thromboembolic Diseases, Selected for Oral Presentation at the 68th ASH Annual Meeting
Syndax to Host ASH Investor Event in Person and via Webcast on December 14, 2026
Corvus Pharmaceuticals Announces Initial Data from Soquelitinib Clinical Trial in Patients with Autoimmune Lymphoproliferative Syndrome (ALPS) will be Presented at the 68ᵗʰ American Society for Hematology Annual Meeting & Exposition
Secura Bio Announces Two Duvelisib Presentations on Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma at the 2026 American Society of Hematology Annual Meeting
Agios to Highlight Strength and Differentiation of Rare Hematology Portfolio with New Clinical Data for Mitapivat in Sickle Cell Disease and AG-236 in Polycythemia Vera at ASH 2026
CRISPR Therapeutics to Present Clinical Data from Zugo-cel in Large B-Cell Lymphoma at the 68th American Society of Hematology (ASH) Annual Meeting and Exposition
Lyell Immunopharma to Present Positive Updated Ronde-Cel Data in More than 80 Patients at ASH 2026 from PiNACLE Pivotal Trial in 3L+ and from Phase 1/2 2L Cohort in Patients with Relapsed/Refractory Large B-Cell Lymphoma

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Telecoms Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.